Europe Insulin Market for Type 1 and Type 2 Diabetes

Published Apr 01, 2025

Length 350 Pages

SKU # DAABD20406728

Description

Europe insulin market for type 1 and type 2 diabetes market is expected to reach USD 6.56 billion by 2032 from USD 4.79 billion in 2024, growing at the CAGR of 4.0% in the forecast period of 2025 to 2032.

Market Segmentation:
Europe Insulin Market for Type 1 And Type 2 Diabetes Segmentation, Type (Type 2 Diabetes and Type 1 Diabetes), Product Type (Long Acting Insulin, Rapid-Acting Insulin, Short Acting Insulin, and Others), Absorption Site (Basal, Bolus, and Others), Age Group (Adult Patients, Geriatric Patients, and Pediatric Patients), Source (Analog Insulin, Human Insulin, and Others), Delivery Method (Insulin Pens, Vial & Syringe, Insulin Pumps, Inhalable Insulin, and Implantable Insulin Delivery Systems), Gender (Male and Female), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, and Diabetes Clinics & Specialty Pharmacies), By Countries (Germany, U.K., France, Italy, Spain, Russia, Netherlands, Switzerland, Belgium, Turkey, Denmark, Norway, Poland, and rest of Europe)- Industry Trends and Forecast to 2032

Overview of Europe Insulin Market for Type 1 And Type 2 Diabetes Market Dynamics:

Driver

• Rising prevalence of diabetes
Restraint

• Adverse effects of high dosage of insulin

Opportunity

• Advancements in insulin formulation and delivery technologies
Market Players:

The key market players operating in the Europe insulin market for type 1 and type 2 diabetes are listed below:

• Novo Nordisk A/S (Denmark)
• Eli Lilly and Company (U.S.)
• Sanofi (France)
• Biocon (India)
• Lupin (India)
• Shanghai Fosun Wanbang (Jiangsu)
• Pharmaceutical Group Co., Ltd. (China)
• Diasome Pharmaceuticals, Inc. (U.S.)
• SciGen Pte. Ltd. (Singapore)
• Wockhardt (India)
• MJ Biopharma Pvt. Ltd. (India)
• Oramed Pharmaceuticals (U.S.)
• Adocia (France)
• Nektar Therapeutics (U.S.)

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of The Europe Oral Insulin Market For Type 1 And Type 2 Diabetes; 1.4 Limitations; 1.5 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Currency And Pricing; 2.5 Dbmr Tripod Data Validation Model; 2.6 Multivariate Modelling; 2.7 Type Lifeline Curve; 2.8 Primary Interviews With Key Opinion Leaders; 2.9 Dbmr Market Position Grid; 2.10 Secondary Sources; 2.11 Assumptions
3 Executive Summary
4 Premium Insights: 4.1 Pestal Analysis; 4.2 Porters Five Forces Analysis; 4.3 Epidemiology; 4.4 Industry Insights; 4.5 Key Marketing Strategies For The Europe Oral Insulin Market (Type 1 & Type 2 Diabetes); 4.6 Mergers And Acquisition; 4.7 Pipeline Anlysis
5 Regulatory: 5.1 Regulatory Framework For The Asia-pacific Oral Insulin Market For Type 1 And Type 2 Diabetes; 5.1.1 Regulatory Approval Process; 5.1.2 Geographies’ Ease Of Regulatory Approval; 5.1.3 Regulatory Approval Pathways (Country-wise); 5.1.4 Licensing And Registration; 5.1.5 Post-marketing Surveillance; 5.1.6 Good Manufacturing Practices (Gmps) Guidelines; 5.2 Regulatory Framework For The North America Oral Insulin Market For Type 1 And Type 2 Diabetes; 5.2.1 Regulatory Approval Process; 5.2.2 Geographies’ Ease Of Regulatory Approval; 5.2.3 Regulatory Approval Pathways (Country-wise); 5.2.4 Licensing And Registration; 5.2.5 Post-marketing Surveillance; 5.2.6 Good Manufacturing Practices (Gmps) Guidelines; 5.3 Regulatory Framework For The South America Oral Insulin Market For Type 1 And Type 2 Diabetes; 5.3.1 Regulatory Approval Process; 5.3.2 Geographies’ Ease Of Regulatory Approval; 5.3.3 Regulatory Approval Pathways (Country-wise); 5.3.4 Licensing And Registration; 5.3.5 Post-marketing Surveillance; 5.3.6 Good Manufacturing Practices (Gmps) Guidelines; 5.4 Regulatory Framework For The Europe Oral Insulin Market For Type 1 And Type 2 Diabetes; 5.4.1 Regulatory Approval Process; 5.4.2 Geographies’ Ease Of Regulatory Approval; 5.4.3 Regulatory Approval Pathways (Country-wise); 5.4.4 Licensing And Registration; 5.4.5 Post-marketing Surveillance; 5.4.6 Good Manufacturing Practices (Gmps) Guidelines; 5.5 Regulatory Framework For The Middle East & Africa (Mea) Oral Insulin Market For Type 1 And Type 2 Diabetes; 5.5.1 Regulatory Approval Process; 5.5.2 Geographies’ Ease Of Regulatory Approval; 5.5.3 Regulatory Approval Pathways (Country-wise); 5.5.4 Licensing And Registration; 5.5.5 Post-marketing Surveillance; 5.5.6 Good Manufacturing Practices (Gmps) Guidelines
6 Market Overview: 6.1 Drivers; 6.1.1 Growing Incidence Of Diabetes Worldwide; 6.1.2 Growing Geriatric Population Encouraging Demand For Non-invasive Diabetes Solutions; 6.1.3 Advancements In Oral Insulin Formulations; 6.1.4 Enhanced Patient Compliance And Convenience With Oral Insulin; 6.2 Restraints; 6.2.1 Adverse Effects Of High Dosage Of Insulin; 6.2.2 High Production And Development Costs Associated With Insulin; 6.3 Opportunities; 6.3.1 Advancements In Oral Insulin Delivery Technologies; 6.3.2 Revolutionizing Diabetes Management With Needle-free Oral Insulin; 6.3.3 Increasing Pharmaceutical Investments And Strategic Collaborations; 6.4 Challenges; 6.4.1 Insulin Accessibility Challenges In Rural And Underserved Regions; 6.4.2 Limited Shelf Life Associated With Oral Insulin
7 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes Market, By Type: 7.1 Overview; 7.2 Type 2 Diabetes; 7.3 Type 1 Diabetes
8 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes Market, By Technology: 8.1 Overview; 8.2 Polymeric Nanoparticles; 8.3 Nanoparticle-based Delivery Systems; 8.4 Encapsulation Technology; 8.5 Lipid-based Nanocarriers
9 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes Market, By Product Type: 9.1 Overview; 9.2 Capsules
10 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes Market, By Absorption Site: 10.1 Overview; 10.2 Intestinal
11 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes Market, By Formulation Type: 11.1 Overview; 11.2 Enteric-coated Oral Insulin
12 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes Market, By Age Group: 12.1 Overview; 12.2 Adult Patients; 12.3 Geriatric Patients; 12.4 Pediatric Patients
13 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes Market, By Gender: 13.1 Overview; 13.2 Male; 13.3 Female
14 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes Market, By Distribution Channel: 14.1 Overview; 14.2 Retail Pharmacies; 14.3 Hospital Pharmacies; 14.4 Online Pharmacies; 14.5 Diabetes Clinics & Specialty Pharmacies
15 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region: 15.1 Europe; 15.1.1 Germany; 15.1.2 France; 15.1.3 U.K.; 15.1.4 Italy; 15.1.5 Russia; 15.1.6 Spain; 15.1.7 Turkey; 15.1.8 Netherland; 15.1.9 Switzerland; 15.1.10 Austria; 15.1.11 Ireland; 15.1.12 Norway; 15.1.13 Poland
16 Company Profile: 16.1 Aphios Corporation; 16.1.1 Company Snapshot; 16.1.2 Pipeline Portfolio; 16.1.3 Recent Updates; 16.2 Biocon; 16.2.1 Company Snapshot; 16.2.2 Revenue Analysis; 16.2.3 Pipeline Product Portfolio; 16.2.4 Recent Development; 16.3 Diabetology Ltd; 16.3.1 Company Snapshot; 16.3.2 Pipeline Portfolio; 16.3.3 Recent Updates; 16.4 Endo Axiom; 16.4.1 Company Snapshot; 16.4.2 Pipeline Portfolio; 16.4.3 Recent Developments; 16.5 Murli Krishna Pharma; 16.5.1 Company Snapshot; 16.5.2 Pipeline Portfolio; 16.5.3 Recent Updates; 16.6 Niedlfree; 16.6.1 Company Snapshot; 16.6.2 Pipeline Portfolio; 16.6.3 Recent Updates; 16.7 Oramed; 16.7.1 Company Snapshot; 16.7.2 Revenue Analysis; 16.7.3 Pipeline Product Portfolio; 16.7.4 Recent Development; 16.8 Transgene Biotek Limited; 16.8.1 Company Snapshot; 16.8.2 Revenue Analysis; 16.8.3 Pipeline Portfolio; 16.8.4 Recent Development
17 Questionnaire
18 Related Reports
List Of Tables: Table 1 Europe Clinical Trial Market For Oral Insulin Market For Type 1 And Type 2 Diabetes; Table 2 Distribution Of Products And Projects By Phase Europe Oral Insulin Market For Type 1 And Type 2 Diabetes; Table 3 Distribution Of Projects By Therapeutic Area And Phase Europe Oral Insulin Market For Type 1 And Type 2 Diabetes; Table 4 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes, By Type, 2018-2032 (Usd Thousand); Table 5 Europe Type 2 Diabetes In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand); Table 6 Europe Type 1 Diabetes In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand); Table 7 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes, By Technology, 2018-2032 (Usd Thousand); Table 8 Europe Polymeric Nanoparticles In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand); Table 9 Europe Nanoparticle-based Delivery Systems In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand); Table 10 Europe Encapsulation Technology In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand); Table 11 Europe Lipid-based Nanocarriers In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand); Table 12 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes, By Product Type, 2018-2032 (Usd Thousand); Table 13 Europe Capsules In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand); Table 14 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes, By Product Type, 2018-2032 (Usd Thousand); Table 15 Europe Intestinal In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand); Table 16 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes, By Formulation Type, 2018-2032 (Usd Thousand); Table 17 Europe Enteric-coated Oral Insulin In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand); Table 18 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes, By Age Group, 2018-2032 (Usd Thousand); Table 19 Europe Adult Patients In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand); Table 20 Europe Geriatric Patients In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand); Table 21 Europe Pediatric Patients In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand); Table 22 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes, By Gender, 2018-2032 (Usd Thousand); Table 23 Europe Male In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand); Table 24 Europe Female In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand); Table 25 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes, By Distribution Channel, 2018-2032 (Usd Thousand); Table 26 Europe Retail Pharmacies In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand); Table 27 Europe Hospital Pharmacies In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand); Table 28 Europe Online Pharmacies In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand); Table 29 Europe Diabetes Clinics & Specialty Pharmacies In Oral Insulin Market For Type 1 And Type 2 Diabetes, By Region, 2018-2032 (Usd Thousand); Table 30 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes Market, By Country, 2028-2032 (Usd Thousand)
List Of Figures: Figure 1 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes: Segmentation; Figure 2 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes: Data Triangulation; Figure 3 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes: Droc Analysis; Figure 4 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes: Europe Vs Regional Market Analysis; Figure 5 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes: Company Research Analysis; Figure 6 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes: Interview Demographics; Figure 7 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes: Dbmr Market Position Grid; Figure 8 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes: Segmentation; Figure 9 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes Executive Summary; Figure 10 Strategic Decisions; Figure 11 Two Segments Comprise The Europe Oral Insulin Market For Type 1 And Type 2 Diabetes, By Type; Figure 12 Growing Incidence Of Diabetes Worldwide Is Expected To Drive The Europe Oral Insulin Market For Type 1 And Type 2 Diabetes Growth In The Forecast Period Of 2026 To 2032; Figure 13 Type 2 Segment Is Expected To Account For The Largest Share Of The Europe Oral Insulin Market For Type 1 And Type 2 Diabetes In The Forecast Period Of 2026 & 2032; Figure 14 Top 10 Countries By The Number Of Adults With Diabetes In 2021; Figure 15 Europe Healthcare Expenditure For Diabetes; Figure 16 Number Of People With Diabetes In 2045 (Millions); Figure 17 Droc Analysis; Figure 18 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes: By Type, 2024; Figure 19 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes: By Type, 2025 To 2032 (Usd Thousand); Figure 20 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes: By Type, Cagr (2025- 2032); Figure 21 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes: By Type, Lifeline Curve; Figure 22 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes: By Technology, 2024; Figure 23 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes: By Technology, 2025 To 2032 (Usd Thousand); Figure 24 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes: By Technology, Cagr (2025- 2032); Figure 25 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes: By Technology, Lifeline Curve; Figure 26 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes: By Product Type, 2024; Figure 27 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes: By Product Type, 2025 To 2032 (Usd Thousand); Figure 28 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes: By Product Type, Cagr (2025- 2032); Figure 29 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes: By Product Type, Lifeline Curve; Figure 30 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes: By Absorption Site, 2024; Figure 31 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes: By Absorption Site, 2025 To 2032 (Usd Thousand); Figure 32 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes: By Absorption Site, Cagr (2025- 2032); Figure 33 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes: By Absorption Site, Lifeline Curve; Figure 34 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes: By Formulation Type, 2024; Figure 35 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes: By Formulation Type, 2025 To 2032 (Usd Thousand); Figure 36 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes: By Formulation Type, Cagr (2025- 2032); Figure 37 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes: By Formulation Type, Lifeline Curve; Figure 38 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes: By Age Group, 2024; Figure 39 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes: By Age Group, 2025 To 2032 (Usd Thousand); Figure 40 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes: By Age Group, Cagr (2025- 2032); Figure 41 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes: By Age Group, Lifeline Curve; Figure 42 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes: By Gender, 2024; Figure 43 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes: By Gender, 2025 To 2032 (Usd Thousand); Figure 44 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes: By Gender, Cagr (2025- 2032); Figure 45 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes: By Gender, Lifeline Curve; Figure 46 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes: By Distribution Channel, 2024; Figure 47 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes: By Distribution Channel, 2025 To 2032 (Usd Thousand); Figure 48 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes: By Distribution Channel, Cagr (2025- 2032); Figure 49 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes: By Distribution Channel, Lifeline Curve; Figure 50 Europe Oral Insulin Market For Type 1 And Type 2 Diabetes: Snapshot

Pricing

Currency Rates

Single User Email from Publisher $3,500
Global Site License Email from Publisher $4,200

How Do Licenses Work?

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now